These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12729513)

  • 21. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
    Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
    Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
    Luo D; Yin H; Xili L; Song J; Wang Z
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New vaccines for Japanese encephalitis.
    Solomon T
    Lancet Neurol; 2008 Feb; 7(2):116-8. PubMed ID: 18207104
    [No Abstract]   [Full Text] [Related]  

  • 24. [Japanese B encephalitis--incidence, clinical picture and prevention in travelers to Eastern Asia].
    Stenbeck JL
    Lakartidningen; 1979 Aug; 76(35):2893-5. PubMed ID: 228131
    [No Abstract]   [Full Text] [Related]  

  • 25. Japanese encephalitis outbreak, Yuncheng, China, 2006.
    Wang LH; Fu SH; Wang HY; Liang XF; Cheng JX; Jing HM; Cai GL; Li XW; Ze WY; Lv XJ; Wang HQ; Zhang DL; Feng Y; Yin ZD; Sun XH; Shui TJ; Li MH; Li YX; Liang GD
    Emerg Infect Dis; 2007 Jul; 13(7):1123-5. PubMed ID: 18214202
    [No Abstract]   [Full Text] [Related]  

  • 26. Japanese encephalitis vaccine for travelers: exploring the limits of risk.
    Shlim DR; Solomon T
    Clin Infect Dis; 2002 Jul; 35(2):183-8. PubMed ID: 12087525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination.
    Konishi E; Shoda M; Kondo T
    Vaccine; 2004 Mar; 22(9-10):1097-103. PubMed ID: 15003636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Japanese encephalitis vaccine including a preliminary report on dengue fever and Chikungunya vaccines.
    Kitaoka M
    Jpn J Med Sci Biol; 1967 Dec; 20 Suppl():41-56. PubMed ID: 4297905
    [No Abstract]   [Full Text] [Related]  

  • 30. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships.
    Tseng HF; Tan HF; Chang CK; Huang WL; Ho WC
    Am J Infect Control; 2003 Nov; 31(7):435-40. PubMed ID: 14639442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.
    Erra EO; Kantele A
    Expert Rev Vaccines; 2015; 14(9):1167-79. PubMed ID: 26162529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland.
    Hatz C; Werlein J; Mutsch M; Hufnagel M; Behrens RH
    J Travel Med; 2009; 16(3):200-3. PubMed ID: 19538582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of Travelers to Asia Requiring Multidose Vaccine Schedules: Japanese Encephalitis and Rabies Prevention.
    Walker XJ; Barnett ED; Wilson ME; Macleod WB; Jentes ES; Karchmer AW; Hamer DH; Chen LH;
    J Travel Med; 2015; 22(6):403-9. PubMed ID: 26420372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the Full Economic Cost for Japanese Encephalitis Under Different Risk Scenarios for Business Travelers to Asia.
    Rogers WH; Bunn WB; Lerner D
    J Occup Environ Med; 2019 Jan; 61(1):16-20. PubMed ID: 30320627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Japanese encephalitis: the need for a more effective vaccine.
    Marfin AA; Gubler DJ
    Lancet; 2005 Oct 15-21; 366(9494):1335-7. PubMed ID: 16226596
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control.
    Igarashi A
    Curr Top Microbiol Immunol; 2002; 267():139-52. PubMed ID: 12082987
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse reactions to Japanese encephalitis vaccine in travellers.
    Nothdurft HD; Jelinek T; Marschang A; Maiwald H; Kapaun A; Löscher T
    J Infect; 1996 Mar; 32(2):119-22. PubMed ID: 8708368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51.
    Dubischar-Kastner K; Eder S; Buerger V; Gartner-Woelfl G; Kaltenboeck A; Schuller E; Tauber E; Klade C
    Vaccine; 2010 Jul; 28(32):5197-202. PubMed ID: 20541581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A field trial of Japanese encephalitis vaccine produced in Thailand.
    Rojanasuphot S; Charoensuk O; Kitprayura D; Likityingvara C; Limpisthien S; Boonyindee S; Jivariyavej V; Ugchusak K
    Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):653-4. PubMed ID: 2561722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.